Phase I Dose-Escalation Trial of BI 2536, a Polo-Like Kinase 1 Inhibitor, in Relapsed and Refractory Non-Hodgkin's Lymphoma
Vose, Julie M., Young, Anas, Friedberg, Jonathan W., Waller, Edmund K., Cheson, Bruce D., Trommeshauser, Dirk, Munzert, Gerd
Published in Blood (16.11.2008)
Published in Blood (16.11.2008)
Get full text
Journal Article